Results 101 to 110 of about 127,027 (324)

Bleeding related to disturbed fibrinolysis

open access: yesBritish Journal of Haematology, 2016
The components and reactions of the fibrinolysis system are well understood. The pathway has fewer reactants and interactions than coagulation, but the generation of a complete quantitative model is complicated by the need to work at the solid‐liquid ...
K. Kolev, C. Longstaff
semanticscholar   +1 more source

Towards Personalised Therapy in Chronic Spontaneous Urticaria: Advancing From Endotype to Clinical Response

open access: yesClinical &Experimental Allergy, EarlyView.
Chronic spontaneous urticaria (CSU) is a debilitating skin disorder with significant impact upon quality of life. Current guidelines advocate stepwise treatment of standard dose antihistamines, high dose antihistamines, omalizumab and ciclosporin.
Katie Ridge   +7 more
wiley   +1 more source

Safety and Efficacy of Hospital Utilization of Tranexamic Acid in Civilian Adult Trauma Resuscitation [PDF]

open access: yes, 2020
Introduction: Patients with trauma-induced coagulopathies may benefit from the use of antifibrinolytic agents, such as tranexamic acid (TXA). This study evaluated the safety and efficacy of TXA in civilian adults hospitalized with traumatic hemorrhagic ...
Borger, Rodney   +13 more
core  

Disease recurrence and rejection following liver transplantation for autoimmune chronic active liver disease [PDF]

open access: yes, 1992
Autoimmune chronic active liver disease (ACALD), a major indication for liver transplantation, is associated strongly with antigenic determinants HLA-B8 and DR3.
Block, GD   +6 more
core   +1 more source

Fibrinolysis: from blood to the brain

open access: yesJournal of Thrombosis and Haemostasis, 2017
We all know about classical fibrinolysis, how plasminogen activation by either tissue‐type plasminogen activator (t‐PA) or urokinase‐type plasminogen activator (u‐PA) promotes fibrin breakdown, and how this process was harnessed for the therapeutic ...
R. Medcalf
semanticscholar   +1 more source

Why, how and in whom should we measure levels of lipoprotein(a): A review of the latest evidence and clinical implications

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Lipoprotein(a) [Lp(a)] is a genetically determined, causal risk factor for atherosclerotic cardiovascular disease (ASCVD) and calcific aortic valve disease (CAVD). Despite robust evidence from epidemiological and genetic studies, Lp(a) remains underrecognised in clinical practice due to challenges in measurement, lack of guideline familiarity ...
Alexander C. Razavi   +4 more
wiley   +1 more source

Concomitant usage of thrombolytic therapy and therapeutic hypothermia in a case of sudden cardiac arrest due to massive pulmonary embolism

open access: yesTürk Kardiyoloji Derneği Arşivi, 2019
Massive pulmonary embolism is a well-known cause of sudden cardiac arrest in the adult population. Systemic fibrinolysis can be a life-saving option. Therapeutic hypothermia is highly recommended for nontraumatic sudden cardiac arrest victims to minimize
Ali Çoner, Tayfun Birtay
doaj   +1 more source

Enhanced Fibrinolysis with Magnetically Powered Colloidal Microwheels.

open access: yesSmall, 2017
Thrombi that occlude blood vessels can be resolved with fibrinolytic agents that degrade fibrin, the polymer that forms between and around platelets to provide mechanical stability.
T. Tasci   +6 more
semanticscholar   +1 more source

Increased packed cell volume alters point of care viscoelastic clotting parameters in horses

open access: yesEquine Veterinary Journal, Volume 57, Issue 3, Page 766-773, May 2025.
Abstract Background Polycythaemia and coagulopathy are identified risk factors for non‐survival in critically ill horses. Assessment of coagulation is recommended for critical care monitoring but may be affected by concurrent polycythaemia. Objective To evaluate the effects of induced polycythaemia on coagulation parameters as measured by a point‐of ...
Rebecca C. Bishop   +5 more
wiley   +1 more source

Successful treatment of refractory gastrointestinal bleeding by systemic (oral) ankaferd blood stopper in a patient with Glanzmann thrombasthenia [PDF]

open access: yes, 2015
Background: Glanzmann Thrombasthenia (GT) is a genetic platelet dysfunction and a life threatening disease. Ankaferd Blood Stopper (ABS) is a topical hemostatic agent of herbal origin which has been recently made available for clinical use.
Doğu, Mehmet Hilmi   +3 more
core   +2 more sources

Home - About - Disclaimer - Privacy